Status | Study |
RECRUITING |
Study Name: Addressing Disability Effectively With Psychosocial Telemedicine Condition: Crohn Disease Date: 2022-11-10 Interventions: 8 weekly 1-hr telemedicine visits with a licensed Ph.D. psychologist from the University of Pennsylvania (permissible to practice across state lines u |
RECRUITING |
Study Name: Addressing Disability Effectively With Psychosocial Telemedicine Condition: Crohn Disease Date: 2022-11-10 Interventions: 8 weekly 1-hr telemedicine visits with a licensed Ph.D. psychologist from the University of Pennsylvania (permissible to practice across state lines u |
RECRUITING |
Study Name: A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy Condition: Crohn Disease Date: 2022-07-12 Interventions: Specific dose on specific days |
RECRUITING |
Study Name: Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease Condition: Crohn Disease Date: 2021-11-16 Interventions: Intravenous administration of bone marrow mesenchymal stem cell derived extracellular vesicles |
RECRUITING |
Study Name: Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial Condition: Crohn Disease Date: 2021-08-26 Interventions: oral AZA capsules at a daily dose of 2.5 mg per kilogram, |
RECRUITING |
Study Name: A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease Condition: Crohn Disease Date: 2021-04-13 |
RECRUITING |
Study Name: Stem Cell Transplantation in Crohn's Disease Condition: Crohn Disease Date: 2018-04-04 Interventions: Stem Cell Mobilization: Infused according to institutional guidelines;Post-PBSC Infusion Conditioning: Mesna provided with Cytoxan according |
Active, not recruiting |
Study Name: Extension Study of MT-1303 in Subjects With Crohn's Disease Condition: Crohn's Disease Date: 2015-03-10 Interventions: Drug: MT-1303 |
Completed |
Study Name: Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease Condition: Crohn's Disease Date: 2015-02-27 Interventions: Drug: MT-1303 Drug: Placebo |
Recruiting |
Study Name: Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease Condition: Crohn's Disease Date: 2014-07-16 Interventions: Dietary Supplement: Placebo 1 |